PharmacyCodes



Ergotamin en es it fr

Ergotamin Brand names, Ergotamin Analogs

Ergotamin Brand Names Mixture

  • No information avaliable

Ergotamin Chemical_Formula

C33H37N5O5

Ergotamin RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Ergotamin fda sheet

Ergotamin FDA

Ergotamin msds (material safety sheet)

Ergotamin MSDS

Ergotamin Synthesis Reference

No information avaliable

Ergotamin Molecular Weight

583.678 g/mol

Ergotamin Melting Point

No information avaliable

Ergotamin H2O Solubility

No information avaliable

Ergotamin State

Solid

Ergotamin LogP

No information avaliable

Ergotamin Dosage Forms

Liquid

Ergotamin Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Ergotamin Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Ergotamin Absorption

Interpatient variable and may be dependent on the administration technique

Ergotamin side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Ergotamin Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45� (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Ergotamin Organisms Affected

Humans and other mammals